ASL
Argininosuccinate lyase
Also known as: ARLY_HUMAN, ASAL
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P04424
- Gene
- ASL
- Ensembl
- ENSG00000126522
- Chromosome
- 7
- Canonical length
- 464 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Cytosol
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
This gene encodes a member of the lyase 1 family. The encoded protein forms a cytosolic homotetramer and primarily catalyzes the reversible hydrolytic cleavage of argininosuccinate into arginine and fumarate, an essential step in the liver in detoxifying ammonia via the urea cycle. Mutations in this gene result in the autosomal recessive disorder argininosuccinic aciduria, or argininosuccinic acid lyase deficiency. A nontranscribed pseudogene is also located on the long arm of chromosome 22. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
464 residues, UniProt reviewed canonical sequence.
>P04424|ASL
1 MASESGKLWG GRFVGAVDPI MEKFNASIAY DRHLWEVDVQ GSKAYSRGLE KAGLLTKAEM
61 DQILHGLDKV AEEWAQGTFK LNSNDEDIHT ANERRLKELI GATAGKLHTG RSRNDQVVTD
121 LRLWMRQTCS TLSGLLWELI RTMVDRAEAE RDVLFPGYTH LQRAQPIRWS HWILSHAVAL
181 TRDSERLLEV RKRINVLPLG SGAIAGNPLG VDRELLRAEL NFGAITLNSM DATSERDFVA
241 EFLFWASLCM THLSRMAEDL ILYCTKEFSF VQLSDAYSTG SSLMPQKKNP DSLELIRSKA
301 GRVFGRCAGL LMTLKGLPST YNKDLQEDKE AVFEVSDTMS AVLQVATGVI STLQIHQENM
361 GQALSPDMLA TDLAYYLVRK GMPFRQAHEA SGKAVFMAET KGVALNQLSL QELQTISPLF
421 SGDVICVWDY GHSVEQYGAL GGTARSSVDW QIRQVRALLQ AQQALocalizationUniProt · AlphaFold · HPA
Whether an antibody against ASL can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 356 nTPM
Expression across tissuesHPA
Tissue
- liver: 356 nTPM
- kidney: 61 nTPM
- duodenum: 57 nTPM
- colon: 52 nTPM
- small intestine: 44 nTPM
- stomach: 43 nTPM
Single-cell type
- hepatocytes: 344 nCPM
- colonocytes: 240 nCPM
- enterocytes: 239 nCPM
- enteric transient amplifying cells: 132 nCPM
- tuft cells: 127 nCPM
- goblet cells: 107 nCPM
Immune cell
- NK-cell: 74 nTPM
- eosinophil: 51 nTPM
- intermediate monocyte: 47 nTPM
- myeloid DC: 46 nTPM
- classical monocyte: 43 nTPM
- non-classical monocyte: 36 nTPM
Brain region
- pons: 14 nTPM
- choroid plexus: 11 nTPM
- hypothalamus: 10 nTPM
- thalamus: 8.8 nTPM
- medulla oblongata: 8.6 nTPM
- midbrain: 8 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ASL.
Disease | AllUniProt
Conditions ASL is implicated in, by any mechanism.
- Argininosuccinic aciduria (ARGINSA) MIM:207900
Disease | GeneticClinVar
239 pathogenic / likely-pathogenic of 964 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Argininosuccinate lyase deficiency
- ASL-related disorder
- Inborn genetic diseases
- Neurodevelopmental disorder
- Acute myeloid leukemia
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.94
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.75
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- arginine metabolic process
- L-arginine biosynthetic process
- L-arginine biosynthetic process via ornithine
- locomotory behavior
- positive regulation of nitric oxide biosynthetic process
- post-embryonic development
- urea cycle
- ammonia assimilation cycle
Molecular functions
- identical protein binding
- argininosuccinate lyase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Fumarate lyase family
- L-Aspartase-like
- Fumarate lyase, conserved site
- Fumarate lyase, N-terminal
- Fumarase/histidase, N-terminal
- Lyase
- Argininosuccinate lyase
- Argininosuccinate lyase, C-terminal
- Argininosuccinate lyase C-terminal
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ASL as an antibody target. Whether an autoantibody or antibody against ASL could matter depends on whether native ASL is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ASL is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ASL as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...